Olon S.p.A. is a worldwide leader in the development and production of APIs (Active Pharmaceutical Ingredients).
The ideal partner for custom synthesis and contract manufacturing projects.

NEWS & EVENTS

Olon Acquires Manufacturing Facility in India

3 September 2018
Olon announced the acquisition of a local manufacturing facility in Mahad, India.
READ MORE

OLON
Institutional Video


November 2018

Discover more about Olon

READ MORE

FESTIVAL 2018 DELL’INNOVAZIONE E DELLA SCIENZA


13 Ottobre 2018 – Vi aspettiamo per Fabbriche Aperte presso lo stabilimento di Settimo Torinese, in via Schiapparelli 2 dalle 16.

Olon on Pharma’s Almanac Magazine


May 2018

Strengthening the outsource service offering through integration...Click the image to read the full article

Olon Announces Investment and Expansion of APIs Manufacturing Capabilities


January 2018

Rodano, Italy – January 26th, 2018 – Between 2016 and 2017, Olon SpA, European leader of API manufacturing, invested more than 10 million € to expand...

READ MORE

OLON acquired RICERCA


June 9th, 2017

OLON SPA (P&R Group) ACQUIRES RICERCA BIOSCIENCES CHEMICAL DIVISION IN OHIO (USA). Acquisition strengthens service offering of global CDMO and Generics provider...

READ MORE
If you need information, speak to one our experts.

FOCUS ON

Recombinant peptides

Olon has developed a recombinant peptide technology that allows to provide its customers with requested peptide on any scale.

Fluorination: a new technology

Olon with its brand new R&D Labs and Reactors for fluorination can now offer a full range of fluorinating processes under cGMP.